Summary
A medRxiv preprint analysing 81,870 UK Biobank participants found that structural deviations with ageing and neurological disease were concentrated in the basal forebrain’s Ch4 compartment. The study also linked Ch4 deficits with later dementia and Parkinson’s disease diagnoses.
A preprint analysis of 81,870 UK Biobank participants found that age- and disease-related differences in the basal forebrain were generally more pronounced in one of its two examined compartments: the nucleus basalis of Meynert, known as Ch4. The structural differences were also detectable before neurological diagnoses and were associated with later dementia and Parkinson’s disease diagnoses, the researchers report.
The study, posted on medRxiv, examined grey-matter volume in adults aged 45 to 87. It found distinct age-related patterns in Ch4 and in the septal and diagonal-band regions grouped as Ch1–3. The findings describe structural patterns in a preprint study; they do not establish that those changes cause the diseases.
How the study compared the two compartments
The basal forebrain provides the principal cholinergic input to the cortex and hippocampus. Cholinergic neurons use acetylcholine to communicate with other cells. The study separated the basal forebrain into Ch4 and Ch1–3 rather than treating it as a single structure.
The researchers built age- and sex-specific reference models of grey-matter volume for each compartment, then measured how individual participants differed from those expected patterns. They assessed these deviations in cross-sectional and longitudinal ageing analyses, in people with neurological and psychiatric disorders, before neurodegenerative diagnoses, and in relation to later disease incidence. They also examined whether common inherited genetic risk could account for the patterns.
Ch4 deviations were more prominent
The two compartments showed distinguishable age-related profiles, and the difference was also present in the longitudinal data. Across neurological diseases, deviations were generally concentrated in Ch4; the researchers report that almost no condition showed greater deviation in Ch1–3.
The Ch4 deficit was detectable years before diagnosis and was associated with incident dementia and Parkinson’s disease. By contrast, Ch1–3 showed no independent prospective structural vulnerability in the analysis. The researchers also found that common inherited genetic risk did not substantially explain the Ch4 pattern.
These results suggest that the basal forebrain’s subregions do not share a uniform structural profile in ageing and neurological disease. Separating them may help researchers describe where structural differences appear and how they relate to disease timing. Grey-matter volume is an anatomical measure, however, not a direct measurement of cholinergic signalling or neuron function. As an observational analysis, the study identifies associations and timing rather than establishing cause and effect.